Literature DB >> 22538441

CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.

Ming-Rui Tang1, Yu-Xin Wang, Shu Guo, Si-Yuan Han, Di Wang.   

Abstract

In this work, we studied the effects of CUB and Sushi multiple domains 1 gene (CSMD1) expression in A375 melanoma cells in vivo and in vitro. CSDM1 expression decreased proliferation and migration, and increased apoptosis and G(1) arrest in A375 cells in vitro. Expression of CSDM1 in established xenografted tumors decreased tumor size and weight, and decreased the density of intratumor microvessels. The survival rate of mice with tumors expressing CSMD1 was significantly higher than mice with tumors that did not express CSDM1. These results confirm the role of CSDM1 as a tumor suppressor gene in melanoma cells. Furthermore, we found that CSMD1 can interact with Smad3, activate Smad1, Smad2, and Smad3, and increase the expression of Smad4. These results might prove helpful for the development of novel therapies for melanoma treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538441     DOI: 10.1007/s10495-012-0727-0

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  26 in total

1.  Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

Authors:  Rui Zhang; Chun Song
Journal:  Tumour Biol       Date:  2014-01-10

2.  Vitamin D analog EB1089 could repair the defective bone marrow-derived mesenchymal stromal cells in patients with systemic lupus erythematosus.

Authors:  Jing-Jing Xu; Yan-Bin Sun; Xiao-Li Zhang; Xiao-Fei Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

Authors:  Beryl Royer-Bertrand; Matteo Torsello; Donata Rimoldi; Ikram El Zaoui; Katarina Cisarova; Rosanna Pescini-Gobert; Franck Raynaud; Leonidas Zografos; Ann Schalenbourg; Daniel Speiser; Michael Nicolas; Laureen Vallat; Robert Klein; Serge Leyvraz; Giovanni Ciriello; Nicolò Riggi; Alexandre P Moulin; Carlo Rivolta
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

Review 4.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

5.  Genomic sites hypersensitive to ultraviolet radiation.

Authors:  Sanjay Premi; Lynn Han; Sameet Mehta; James Knight; Dejian Zhao; Meg A Palmatier; Karl Kornacker; Douglas E Brash
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-13       Impact factor: 11.205

6.  Mutational landscape of basal cell carcinomas by whole-exome sequencing.

Authors:  Shyam S Jayaraman; David J Rayhan; Salar Hazany; Michael S Kolodney
Journal:  J Invest Dermatol       Date:  2013-06-17       Impact factor: 8.551

7.  Kisspeptin 10 inhibits the Warburg effect in breast cancer through the Smad signaling pathway: both in vitro and in vivo.

Authors:  Guo-Qing Song; Yi Zhao
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

8.  Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

Authors:  German Reyes-Botero; Marine Giry; Karima Mokhtari; Marianne Labussière; Ahmed Idbaih; Jean-Yves Delattre; Florence Laigle-Donadey; Marc Sanson
Journal:  J Neurooncol       Date:  2013-11-17       Impact factor: 4.130

9.  PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.

Authors:  Wei Wang; Xiao-Wen Song; Xian-Min Bu; Ning Zhang; Cheng-Hai Zhao
Journal:  Cell Oncol (Dordr)       Date:  2015-11-20       Impact factor: 6.730

10.  Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.

Authors:  Hao Feng; Xiao-Min Jia; Ni-Na Gao; Hua Tang; Wei Huang; Ning Ning
Journal:  Cell Cycle       Date:  2019-09-04       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.